Skip to content
Subscriber Only
Business
Prognosis

U.S. Case Rise Slows; Gilead Sets Remdesivir Use: Virus Update

Video player cover image
When and How Will the Coronavirus Pandemic End?
Updated on

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

U.S. cases increased 2.3% in the past 24 hours, below the one-week daily average. Gilead Sciences Inc. plans to get its drug remdesivir to patients within days after getting U.S. backing for emergency use.